Boosters improve diminished protection against Omicron infection after basic COVID-19 vaccination or previous infection Vaccination or previous infection with the coronavirus SARS-CoV-2 provide less effective protection against the Omicron variant compared to the Delta variant. A COVID-19 booster vaccination ensures renewed protection against Omicron.
Start cervical cancer screening on Saba February 7th 2022, a pilot for population screening for cervical cancer will start on Saba. All women between 30 and 60 years, will be invited to participate in the coming three years.
Over half a million positive COVID-19 tests, more hospital admissions Last week*, 530,015 positive COVID-19 tests were reported to RIVM**. That is an increase of 45% compared to the week before that. The number of new hospital admissions rose by 11% in the past week. ICU admissions rose by 18%.
Staying 1.5 metres apart is growing more difficult Staying 1.5 metres apart seems to be more and more difficult for people to manage.
Blockchain technology and infectious disease control Blockchain technology is, in principle, an applicable technique to strengthen the accessibility, traceability and controllability in the international sharing of samples and data for infectious dis
Mortality still significantly elevated between 30 April and 6 May, but much lower than in previous weeks The total mortality rate in the Netherlands was significantly elevated in the week of 30 April to 6 May 2020. However, excess mortality was much lower than in previous weeks.
The 1.5-metre society is difficult to maintain Personal hygiene measures, such as not shaking hands, or using paper tissues, are not considered a problem by most Dutch people.
Emissions of greenhouse gases slightly lower again in 2019 Emissions of greenhouse gases in the Netherlands were 3% lower in 2019 than in 2018.
COVID-19 in nursing homes is stabilising The number of new nursing homes with COVID-19 patients is stabilising.
Rapid diagnostic tests are not reliable The Serology Task Force of the National Coordination Centre for Testing Capacity – a partnership between RIVM, hospitals and laboratories – has collected research results on rapid diagnostic tests